“If we don’t include women in trials, we are not protecting women” – dolutegravir in pregnant women living with HIV
Many people in African PrEP programmes stop and restart PrEP
Depo Provera may worsen tenofovir-related bone loss in young women
COVID-19 has had a major impact on PrEP, sexual behaviour and service provision
A second study finds introducing PrEP to Africa considerably reduces HIV infections in women
New assay finds low levels of intact proviral DNA in HIV elite controllers
HIV raises the risk of death from COVID-19 in South Africa’s Western Cape
Aged five, uninfected children of HIV-positive mothers do just as well as children of HIV-negative mothers, South African study shows
Vertical transmission rate of 1.8% in Khayelitsha, South Africa
